Navigation Links
Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics
Date:10/8/2007

MURRYSVILLE, Pa., Oct. 8 /PRNewswire-FirstCall/ -- Dixtal Medical, Inc. and Respironics, Inc. (Nasdaq: RESP) announced today that Dixtal Medical has acquired the Novametrix pulse oximetry product line from Respironics. This pulse oximetry product line will be marketed under the Dixtal/Novametrix brand pursuant to Dixtal Medical's license of the Novametrix name from Respironics. Novametrix, founded in 1978 and acquired by Respironics in 2002, established a market-leading position in reusable pulse oximetry sensor technology and has been marketing its oximetry products for over 20 years with an emphasis on high performance, cost-effective, reusable sensors.

Dixtal Medical is a subsidiary of Dixtal Biomedica, an international medical products company based in Brazil and also established in 1978. Dixtal Biomedica is the market leader in multi-parameter monitoring products in Brazil. Dixtal Biomedica and Novametrix have conducted business together for many years, with Dixtal Biomedica manufacturing and marketing Novametrix pulse oximetry products for the Brazilian hospital market.

After Respironics' 2002 acquisition of Novametrix Medical Systems, Respironics integrated the Novametrix pulse oximetry product line into Respironics' Critical Care business. Respironics later determined that the Novametrix pulse oximetry product line was not a core technology for Respironics and made the decision to exit this line of business and refocus on its core technologies. Respironics announced its intention to exit the Novametrix pulse oximetry business in its July 2007 quarterly earnings release conference call and included the impact of this divestiture in its guidance. The sale of the Novametrix pulse oximetry business is not a material transaction for Respironics.

The sale of the Novametrix pulse oximetry business to Dixtal Medical will result in a company dedicated to the Novametrix pulse oximetry technology continuing to serve the Novametrix pulse oximetry customer base. Respironics will continue to market and sell its core multi-parameter monitoring products that contain pulse oximetry as these multi-parameter products, such as the NICO2(R), Tidal Wave(R) and CO2SMO(R) monitors, are not being sold to Dixtal Medical.

Dixtal Medical will initially focus on establishing the Dixtal/Novametrix pulse oximetry brand products with a customer-centric organization designed to support the worldwide installed base of hospitals which are utilizing Novametrix pulse oximetry products. Dixtal Medical will continue to develop the Dixtal/Novametrix pulse oximetry products and eventually will import, market, service and support Dixtal Biomedica multi-parameter monitoring systems for domestic and worldwide markets.

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and healthcare providers. Respironics markets its products in 141 countries and employs over 5,100 associates worldwide. Further information can be found on the Company's Web site: http://www.respironics.com.

FORWARD-LOOKING STATEMENT

This document contains forward-looking statements, including statements relating to, among other things, developments in the healthcare industry; the success of the Company's marketing, sales, and promotion programs; future sales, acceptance, and quality of the Company's products and programs; the results of clinical trials; the timing and success of new product introductions; new product development; anticipated cost savings; FDA and other regulatory requirements, enforcement actions, product recalls or related field actions; future results from acquisitions and strategic investments; growth rates in foreign markets; regulations and other factors affecting operations and sales outside the United States; foreign currency fluctuations; the effects of a major natural disaster, cyber-attack or other catastrophic event that results in the destruction or disruption of any critical business or information technology systems; customer consolidation and concentration; increasing price competition and other competitive factors in the manufacture, distribution, and sale of products; interest rate fluctuations; expiration of intellectual property rights; intellectual property and related litigation; other litigation; future levels of earnings and revenues; the number of equity awards granted to employees and changes in the Company's stock price; and third party reimbursement; all of which are subject to change. Actual results may differ materially from those described in any forward-looking statements. Additional information on potential factors that could affect the Company's financial results are included in the reports filed with the SEC, including the reports on Form 10-K, 10-Q and 8-K.


'/>"/>
SOURCE Respironics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... American ... chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at ... held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and products recently hosted the first PowerWave Instructor Certification Course in Stoughton, Massachusetts. ... a group of fitness professional through the 8 hour interactive course to qualify ...
(Date:5/26/2016)... ... May 26, 2016 , ... On May 23rd during ... Water Life Science® and international water advocate, was honored by Ashram, Inc. as the ... ancient Egypt who knelt on the banks of the Nile to fill their red ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite ... sales leadership and to further develop their rapidly expanding portfolio of customer and ... with a concentration in Marketing and an M.B.A. with concentration in management from ...
(Date:5/26/2016)... ... , ... May 2016 – Lips may be a central feature on our ... numbers of clients now ask about lip plumping and primping techniques and want tips ... Advanced Dermatology P.C. , The trend is a national one, with 2.4 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... CHESTERFIELD, Va. , May 25, 2016 /PRNewswire/ ... next-generation sequencing test for wounds and infections. This ... ALL parasites, and select viruses. The test requires ... area. David G. Bostwick ... molecular testing to facilitate wound healing: "We are ...
(Date:5/25/2016)... 2016 ReportsnReports.com adds "Chronic ... that provides an overview on therapeutic pipeline of ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Chronic Cough ...
(Date:5/24/2016)...   , Study met ... bowel cleansing and superiority in , ... of the ascending colon   ... Norgine B.V. today announced new positive data from the phase ... preparation) versus standard 2 litre PEG with ascorbate. The study met ...
Breaking Medicine Technology: